Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.

Abstract

Cannabinoid CB1 and CB2 receptors are located at key sites involved in the relaying and processing of noxious inputs. Both CB1 and CB2 receptor agonists have analgesic effects in a range of models of inflammatory and neuropathic pain. Importantly, clinical trials of cannabis-based medicines indicate that the pre-clinical effects of cannabinoid agonists may translate into therapeutic potential in humans. One of the areas of concern with this pharmacological approach is that CB1 receptors have a widespread distribution in the brain and that global activation of CB1 receptors is associated with adverse side effects. Studies of the endogenous cannabinoids (endocannabinoids) have demonstrated that they are present in most tissues and that in some pain states, such as neuropathic pain, levels of endocannabinoids are elevated at key sites involved in pain processing. An alternative approach that can be used to harness the potential therapeutic effects of cannabinoids is to maximise the effects of the endocannabinoids, the actions of which are terminated by re-uptake and metabolism by various enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) and cyclooxygenase type 2 (COX2). Preventing the metabolism, or uptake, of endocannabinoids elevates levels of these lipid compounds in tissue and produces behavioural analgesia in models of acute pain. Herein we review recent studies of the effects of inhibition of metabolism of endocannabinoids versus uptake of endocannabinoids on nociceptive processing in models of inflammatory and neuropathic pain.

• Authors: M D Jhaveri, D Richardson, V Chapman
• Journal: British journal of pharmacology (Br J Pharmacol) Vol. 152 Issue 5 Pg. 624-32 (Nov 2007) ISSN: 0007-1188 [Print] England
• PMID: 17704819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Cannabinoid Receptor Antagonists
• Cannabinoid Receptor Modulators
• Endocannabinoids
• Receptors, Cannabinoid

Topics

• Animals
• Cannabinoid Receptor Antagonists
• Cannabinoid Receptor Modulators (metabolism, pharmacokinetics)
• Endocannabinoids
• Humans
• Inflammation (metabolism, physiopathology, prevention & control)
• Models, Biological
• Pain (metabolism, physiopathology, prevention & control)
• Receptors, Cannabinoid (physiology)